Antisense Oligonucleotides as Pharmacological Modulators of Gene Expression

  • G. Degols
  • J.-P. Leonetti
  • B. Lebleu
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 100)


Sequence specific interactions between nucleic acids, through Watson-Crick base pairing, or between nucleic acids and proteins, through well defined recognition rules, govern all steps of gene expression.


Human Immunodeficiency Virus Antisense Oligonucleotide Synthetic Oligonucleotide Pharmacological Modulator Human Immunodeficiency Virus Reverse Transcriptase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Agrawal S, Goodchild J, Civeira MP, Thornton AH, Sarin PS, Zamecnik PC (1988) Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus. Proc Natl Acad Sci USA 85: 7079–7083PubMedGoogle Scholar
  2. Agris CH, Blake K, Miller P, Reddy M, Ts’o POP (1986) Inhibition of vesicular stomatitis virus protein synthesis and infection by sequence-specific oligodeoxyribonucleoside methylphosphonates. Biochemistry 25: 6268–6275PubMedGoogle Scholar
  3. Arad G, Hershkovitz M, Panet A, Loyter A (1986) Use of reconstituted Sendai virus envelopes for fusion-mediated microinjection of double-stranded RNA: inhibition of protein synthesis in interferon-treated cells. Biochim Biophys Acta 859: 88–94PubMedGoogle Scholar
  4. Arnold LJ (1985) Polylysine drug conjugates. Methods Enzymol 112: 270–285PubMedGoogle Scholar
  5. Babkin IV, Boutorin AS, Ivanova EM, Ryte AF (1988) Study of chemical conversion of radioactive (iV-2-chloroethyl-iV-methylamino)benzyl 5’—32P—phosphamide of oligodeoxyribonucleotides in vivo. Biokhemiia 53: 384–393Google Scholar
  6. Bartkiewicz M, Gold HA, Altman S (1989) Identification and characterization of an RNA molecule that copurifies with RNase P activity from HeLa cells. Genes Dev 3: 488–499PubMedGoogle Scholar
  7. Basile D, Mir LM, Paoletti C (1989) Voltage-dependent introduction of [alpha] octothymidylate into electropermeabilized cells. Biochem Biophys Res Commun 159: 633–639Google Scholar
  8. Bass BL, Weintraub H (1987) A developmentally regulated activity that unwinds RNA duplexes. Cell 48: 607 - 613PubMedGoogle Scholar
  9. Bass BL, Weintraub H (1988) An unwinding activity that covalently modifies its double-stranded RNA substrate. Cell 55: 1089–1098PubMedGoogle Scholar
  10. Becker D, Meier CB, Herlyn M (1989) Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor. EMBO J 8: 3685–3691PubMedGoogle Scholar
  11. Berkowitz LA, Riabowol KT, Gilman MZ (1989) Multiple sequence elements of a single functional class are required for cyclic AMP responsiveness of the mouse c- fos promoter. Mol Cell Biol 9: 4272–4281PubMedGoogle Scholar
  12. Bertrand JR, Imbach JL, Paoletti C, Malvy C (1989) Comparative activity of a- and anomeric oligonucleotides on rabbit P globin synthesis: inhibitory effect of CAP targeted α-oligonucleotides. Bioch Biophys Res Commun 164: 311–318Google Scholar
  13. Bonte F, Juliano RL (1986) Interaction of liposomes with serum proteins. Chem Phys Lipids 40: 359–371PubMedGoogle Scholar
  14. Boutorin AS, Vlassov W, Kazakov SA, Kutiavin IV, Podymnogin MA (1984) Complementary addressed reagents carrying EDTA-Fe(II) groups for directed cleavage of single-stranded nucleic acids. FEBS Lett 172: 43–46Google Scholar
  15. Boutorin AS, Gusvkova LV, Ivanova EM, Kobetz ND, Zarytova VF, Ryte AS, Yurchenko LV, Vlassov VV (1989) Synthesis of alkylating oligonucleotide derivatives containing cholesterol or phenazinium residues at their 3’-terminus and their interaction within mammalian cells. FEBS Lett 254: 129–132PubMedGoogle Scholar
  16. Cameron H, Jennings PA (1989) Specific gene suppression by engineered ribozymes in monkey cells. Proc Natl Acad Sci USA 86: 9139–9143PubMedGoogle Scholar
  17. Chen CHB, Sigman DS (1986) Nuclease activity of 1.10-phenantroline-copper: sequence-specific targetting. Proc Natl Acad Sci USA 83: 7147–7151PubMedGoogle Scholar
  18. Coleman J, Green PJ, Inouye M (1984) The use of RNAs complementary to specific mRNAs to regulate the expression of individual bacterial gene. Cell 37: 429–436PubMedGoogle Scholar
  19. Cooney M, Czernuszewicz G, Postel EH, Flint SJ, Hogan ME (1988) Site-specific oligonucleotide binding represses transcription of the human c-myc gene in vitro. Science 241: 456–459PubMedGoogle Scholar
  20. Cotten M, Schaffner G, Birnstiel ML (1989) Ribozyme, antisense RNA, and antisense DNA inhibition of U7 small nuclear ribonucleoprotein-mediated histone pre- mRNA processing in vitro. Mol Cell Biol 9: 4479–4487PubMedGoogle Scholar
  21. Dash P, Lotan I, Knapp M, Kandel ER, Goelet P (1987) Selective elimination of mRNAs in vivo: Complementary oligodeoxynucleotides promote RNA degradation by an RNAse H-like activity. Proc Natl Acad Sci USA 84: 7896–7900Google Scholar
  22. Degols G, Leonetti JP, Gagnor C, Lemaitre M, Lebleu B (1989) Antiviral activity and possible mechanisms of action of oligonucleotides-poly(L-lysine) conjugates targeted to vesicular stomatitis virus mRNA and genomic RNA. Nucleic Acids Res 17: 9341–9350PubMedGoogle Scholar
  23. Dervan PB (1989) oligonucleotide recognition of double-helical DNA by triple helix formation. In: Cohen JS (ed) Oligodeoxynucleotides antisense Inhibitors of gene expression, pp 197–210Google Scholar
  24. Ehresmann C, Baudin F, Mougel M, Romby P, Ebel JP, Ehresmann B (1987) Probing the structure of RNAs in solution. Nucleic Acids Res 15: 9109–9128PubMedGoogle Scholar
  25. Eppstein DA, Longenecker JP (1988) Alternative delivery systems for peptides and proteins as drugs. CRC Crit Rev Ther Drug Carrier Sys 5: 99–139Google Scholar
  26. Fiume L, Busi C, Mattioli A, Spinosa G (1988) Targeting of antiviral drugs bound to protein carriers. CRC Crit Rev Ther Drug Carrier Syst 4: 265–284Google Scholar
  27. Froehler B, Ng P, Matteucci M (1988) Phosphoramidate analogues of DNA: synthesis and thermal stability of heteroduplexes. Nucleic Acids Res 16: 4831–4839PubMedGoogle Scholar
  28. Furdon PJ, Dominski Z, Kole R (1989) RNase H cleavage of RNA hybridized to oligonucleotides containing methylphosphonate, phosphorothioate and phos- phodiester bonds. Nucleic Acids Res 17: 9193–9204PubMedGoogle Scholar
  29. Gagnor C, Bertrand JR, Thenet S, Lemaitre M, Morvan F, Rayner B, Malvy C, Lebleu B, Imbach JL, Paoletti C (1987) Alpha-DNA VI: comparitive study of alpha- and beta-anomeric oligonucleotides in hybridization to mRNA and in cell- free translation inhibition. Nucleic Acids Res 15: 1049–10436Google Scholar
  30. Gagnor C, Rayner B, Leonetti JP, Imbach JL, Lebleu B (1989) Parallel annealing of alpha anomeric oligodeoxyribonucleotides to natural mRNA is required for interference in RNase H mediated hydrolysis and reverse transcription. Nucleic Acids Res 17: 5107–5113PubMedGoogle Scholar
  31. Gewirtz AM, Anfossi G, Venturelli D, Valpreda S, Sims R, Calabretta B (1989) GJS transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb. Science 24: 180–183Google Scholar
  32. Goodchild J, Agrawal S, Civeira MP, Sarin PS, Sun D, Zamecnik PC (1988) Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides. Proc Natl Acad Sci USA 85: 5507–5511PubMedGoogle Scholar
  33. Grandas A, Marshall WS, Nielsen J, Caruthers MH (1989) Synthesis of deoxycytidine oligomers containing phosphorodithioate linkages. Tetrahedron Lett 30: 543–546Google Scholar
  34. Green PJ, Pines O, Inouye M (1986) The role of antisense RNA in gene regulation. Annu Rev Biochem 55: 569–597PubMedGoogle Scholar
  35. Gregoriadis G (ed) (1988) Liposomes as drug carriers. Recent trends and progress. Wiley, ChichesterGoogle Scholar
  36. Griffin LC, Dervan PB (1989) Recognition of thymine adenine base pairs by guanine in a pyrimidine triple helix motif. Science 245: 967–970PubMedGoogle Scholar
  37. Gupta KC (1987) Antisense oligodeoxynucleotides provide insight into mechanism of translation initiation of two Sendai virus mRNAs. J Biol Chem 262: 7492–7496PubMedGoogle Scholar
  38. Haseloff J, Gerlach WL (1988) Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature 334: 585–591PubMedGoogle Scholar
  39. Helene C, Montenay-Garestier T, Saison I, Takasugi M, Toulme JJ, Asseline U, Lancelot G, Maurizot JC, Toulme F, Thuong NT (1985) Oligodeoxynucleotidescovalently linked to intercalating agents: a new class of gene regulatory substances. Biochimie 67: 777–783PubMedGoogle Scholar
  40. Helenius A, Doxsey S, Hellman I (1987) Viruses as tools in drug delivery. In: Biological approaches to the controlled delivery of drugs. Ann NY Acad Sci 507: 1–6Google Scholar
  41. Hoogsteen K (1959) The stucture of crystals containing a hydrogen-bonded complex of 1-methylthymine and 9-methyladenine. Acta Cristallogr 12: 822–823Google Scholar
  42. Hugues BJ, Kennel S, Lee R, Huang L (1989) Monoclonal antibody targeting of liposomes to mouse lung in vivo. Cancer Res 49: 6124–6220Google Scholar
  43. Izant JG, Weintraub H (1984) Inhibition of thymidine kinase gene expression by antisense RNA: a molecular approach to genetic analyses. Cell 36: 1007–1015PubMedGoogle Scholar
  44. Kaneda Y, Iwai K, Uchida T (1989) Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science 243: 375–378PubMedGoogle Scholar
  45. Kim SK, Wold B (1985) Stable reduction of thymidine kinase activity in cells expressing high levels of antisense RNA. Cell 42: 129–138PubMedGoogle Scholar
  46. Kim SC, Podhajska Aj, Szybalski W (1988) Cleaving DNA at any predetermined site with adapter-primers and class-IIS restriction enzymes. Science 240: 504–506PubMedGoogle Scholar
  47. Knight DE, Scrutton MC (1986) Gaining access to the cytosol: the technique and some applications of electropermeabilization. Biochem J 234: 497–506PubMedGoogle Scholar
  48. Knorre DG, Vlassov VV, Zarytova VF, Karpova GG (1985) Nucleotide and oligonucleotide derivatives as enzyme and nucleic acid targeted irreversible inhibitors. Chemical aspects. Adv Enzyme Regul 24: 277–300Google Scholar
  49. Knorre V, Vlassov VV, Zarytova VF (1985) Reactive oligonucleotide derivatives and sequence-specific modification of nucleic acids. Biochimie 67: 785–789PubMedGoogle Scholar
  50. Knorre V, Vlassov VV, Zarytova VF (1989) Oligonucleotides linked to reactive groups. In: Cohen JS (ed) Oligodeoxynucleotides: antisense inhibitors of gene expression. Macmillan, London, p 173 Kulka M, Smith CC, Aurelian L, Fishelevich R, Meade K, Ts’o POP (1989) Site specificity of the inhibitory effects of oligo(nucleoside methylphosphonate)s complementary to the acceptor splic junction of herpes simplex virus type 1 immediate early mRNA 4. Proc Natl Acad Sci USA 86: 6868–6872Google Scholar
  51. Lamond Al, Sproat B, Ryder U, Hamm J (1989) Probing the structure and function of U2 snRNP with antisense oligonucleotides made of 2′-9-Me-RNA. Cell 58: 383–390PubMedGoogle Scholar
  52. Lawson TG, Ray BK, Dodds JT, Grifo JA, Abramson RD, Merrick WC, Betsch DF, Veith HL, Thach RE (1986) Influence of 5′ proximal secondary structure on the translation efficiency of eukaryotic mRNAs and on their interaction with initiation factors. J Biol Chem 261: 13979–13989PubMedGoogle Scholar
  53. Lee BL, Murakami A, Blake KR, Lin SB, Miller PS (1988) Interaction of psoralen- derivatized oligodeoxyribonucleoside methylphosphonates. Biochemistry 27: 3197–3203PubMedGoogle Scholar
  54. Lemaitre M, Bayard B, Lebleu B (1987) Specific antiviral activity of a poly(L-lysine)- conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site. Proc Natl Acad Sci USA 84: 648–652Google Scholar
  55. Leonetti JP, Rayner B, Lemaitre M, Gagnor C, Milhaud PG, Imbach JL, Lebleu B (1988) Antiviral activity of conjugates between poly(L-lysine) and synthetic oligodeoxyribonucleotides. Gene 72: 323–332PubMedGoogle Scholar
  56. Leonetti JP, Machy P, Degols G, Lebleu B, Leserman L (1990b) Antibody-targeted liposomes containing oligodeoxyribonucleotide sequences complementary to viral RNA selectively inhibit viral replication. Proc Natl Acad Sci USA 87: 2448–2451PubMedGoogle Scholar
  57. Leonetti JP,Degols G, Lebleu B (1990a) Biological activity of oligonucleotide-poly(L-lysine) conjugates: mechanism of cell uptake. Bioconjugate Chem 1: 149 - 153Google Scholar
  58. Lesnikowski ZJ, Jaworska M, Stec WJ (1988) Stereoselective synthesis of P-homochiral oligo(thymidine methanephosphonates). Nucleic Acids Res 16: 11675–11689PubMedGoogle Scholar
  59. Letsinger RL, Zhang G, Sun DK, Ikeuchi T, Sarin P (1989) Cholesteryl conjugated oligonucleotides: synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture. Proc Natl Acad Sci USA 86: 6553–6556PubMedGoogle Scholar
  60. Loke SL, Stein C, Zhang X, Avigan M, Cohen J, Neckers LM (1988) Delivery of c- myc antisense phosphorothioate oligodeoxynucleotide to hematopoietic cells in culture by liposome fusion: specific reduction in c-myc protein expression correlates with inhibition of cell growth and DNA synthesis. Curr Top Microbiol Immunol 141: 282–289PubMedGoogle Scholar
  61. Loke SL, Stein CA, Zhang XH, Mori K, Nakanishi M, Subasinghe C, Cohen JS, Neckers LM (1989) Characterization of oligonucleotide transport into living cells. Proc Natl Acad Sci USA 86: 38474–3478Google Scholar
  62. Maher LJ, III Dolnick BJ (1988) Comparative hybrid arrest by tandem antisense oligodeoxyribonucleotides or oligodeoxyribonucleoside methylphosphonates in a cell-free system. Nucleic Acids Res 16: 3341–3357PubMedGoogle Scholar
  63. Maher LJ, III Wold B, Dervan PB (1989) Inhibition of DNA binding proteins by oligonucleotide-directed triple helix formation. Science 245: 725–730PubMedGoogle Scholar
  64. Majumdar C, Stein CA, Cohen JS, Broder S, Wilson SH (1989) Stepwise mechanism of HIV reverse transcriptase: primer function of phosphorothioate oligodeoxy¬nucleotide. Biochemistry 28: 1340–1346PubMedGoogle Scholar
  65. Marcus-Sekura CJ, Woerner AM, Shinozuka K, Zon G, Quinnan GV (1987) Comparative inhibition of chloramphenicol acetyltransferase gene expression by antisense oligonucleotide analogues having alkyl phosphotriester, methylphosphonate and phosphorothioate linkage. Nucleic Acids Res 15: 5749–5763PubMedGoogle Scholar
  66. Matsukura M, Shinozuka K, Zon G, Mitsuya H, Reitz M, Cohen JS, Broder S (1987) Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus. Proc Natl Acad Sci USA 84: 7706–7710PubMedGoogle Scholar
  67. Matsukura M, Zon G, Shinozuka K, Robert-Guroff M, Shimada T, Stein CA, Mitsuya H, Wong-Sthall F, Cohen JS, Broder S (1989) Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells. Proc Natl Acad Sci USA 86: 4244–4248PubMedGoogle Scholar
  68. McSwiggen JA, Cech TR (1989) Stereochemistry of RNA cleavage by the Tetrahymena ribozyme and evidence that the chemical step is not rate-limiting. Science 244: 679–683PubMedGoogle Scholar
  69. Miller PS, Ts’o POP (1987) A new approach to chemotherapy based on molecular biology and nucleic acid chemistry: matagen (masking tape for gene expression). Anticancer Drug Design 2: 117–128Google Scholar
  70. Miller PS, Barret JC, Ts’o POP (1974) Synthesis of oligodeoxyribonucleotide ethylphosphorodiesters and their specific complex formation with transfer ribonucleic acid. Biochemistry 13: 4887–4896PubMedGoogle Scholar
  71. Miller PS, Braiterman LT, Ts’o POP (1977) Effects of a trinucleotide ethyl phosphotriester, Gmp(ET)Gmp(ET)U, on mammalian cells in culture. Biochemistry 16: 1977–1996Google Scholar
  72. Miller PS, Yano J, Yano E, Caroll C, Jayaraman K, Ts’o POP (1979) Non ionic nucleic acid analogues synthesis and characterization of dideoxyribonucleotide methylphosphonates. Biochemistry 18: 5134 - 5143PubMedGoogle Scholar
  73. Minshull J, Hunt T (1987) The use of single-stranded DNA and RNAse H to promote quantitative “hybrid arrest of translation” of mRNA/DNA hybrids in reticulocyte lysate cell-free translation. Nucleic Acids Res 16: 6433–6451Google Scholar
  74. Mori K, Boiziau C, Cazenave C, Matsukura M, Subasunghe C, Cohen JS, Broder S, Toulme JJ, Stein CA (1989) Phosphoroselenoate oligodeoxynucleotides:synthesis, physico-chemical characterization, anti-sense inhibitory properties and anti HIV activity. Nucleic Acids Res 17: 8207–8219PubMedGoogle Scholar
  75. Morvan F, Rayner B, Imbach JL, Chang DK, Lown JW (1986) a-DNA I. Synthesis, characterization by high field XH-NMR, and base-pairing properties of the unnatural hexadeoxyribonucleotide a- d(CpCpTpTpCpC) with its complement d(GpGpApApGpG). Nucleic Acids Res 14: 5019–5035Google Scholar
  76. Neville DM Jr (1987) Immunotoxins for in vivo therapy: where are we? In: Biological approaches to the controlled delivery of drugs. Ann NY Acad Sci 507: 155Google Scholar
  77. Quartin RS, Wetmur JG (1989) Effect of ionic strength on the hybridation of oligonucleotides with reduced charge due to methylphosphonate linkages to unmodified oligodeoxynucleotides containing the complementary sequence. Biochemistry 28: 1040–1047PubMedGoogle Scholar
  78. Rayner B, Matsukura M, Morvan F, Cohen JS, Imbach JL (1990) Activite anti-VIH in vitro d’oligonucleotides α-phosphorothioates d’anomeried. C R Acad Sci Paris 310 [III]: 61 - 65Google Scholar
  79. Rebagliati MR, Melton DA (1987) Antisense RNA injections in fertilized frog eggs reveal an RNA duplex unwinding activity. Cell 48: 599–605PubMedGoogle Scholar
  80. Rothenberg M, Jonhson G, Laughlin C, Green I, Cradock J, Sarver N, Cohen JS (1989) Oligodeoxynucleotides as anti-sense inhibitors of gene expression: therapeutic implications. JNCI 81: 1539–1544PubMedGoogle Scholar
  81. Sarin PS, Agrawal S, Civeira MP, Goodchild J, Ikeuchi T, Zamecnik PC (1988) Inhibition of acquired immunodeficiency syndrome virus by oligodeoxynucleotide methylphosphonates. Proc Natl Acad Sci USA 85: 7448–7451PubMedGoogle Scholar
  82. Shen WC, Ryser H-P (1978) Conjugation of poly-L-lysine to albumin and horseradish peroxidase: a novel method of enhancing the cellular uptake of proteins. Proc Natl Acad Sci USA 75: 1872–1876PubMedGoogle Scholar
  83. Shi YB, Hearst JE (1986) Thermostability of double-stranded deoxyribonucleic acids: effects of covalent additions of a psoralen. Biochemistry 25: 5895–5902PubMedGoogle Scholar
  84. Shibahara S, Mukai S, Nishiara T, Inouye H, Ohtska E, Morisawa H (1987) Site-directed cleavage of RNA. Nucleic Acids Res 15: 4403–4415PubMedGoogle Scholar
  85. Shibahara S, Mukai S, Morisawa H, Nakashima H, Kobayashy S, Yamamoto N (1989) Inhibition of human immunodeficiency virus (HIV-1) replication by synthetic oligo-RNA derivatives. Nucleic Acids Res 17: 239–252PubMedGoogle Scholar
  86. Smith CC, Aurelian L, Reddy MP, Miller PS, Ts’o POP (1986) Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNA 4 and 5. Proc Natl Acad Sci USA 80: 3232 - 3236Google Scholar
  87. Smith CJS, Watson CF, Ray J, Bird CR, Morris PC, Schuch W, Grierson D (1988) Antisense RNA inhibition of polygalacturonase gene expression in tomatoes. Nature 334: 724–726Google Scholar
  88. Sproat BS, Lamond Al, Beijer B, Neuner P, Ryder U (1989) Highly efficient chemical synthesis of 2′-0-methyloligoribonucleotides and tetrabiotinylated derivative; novel probes that are resistant to degradation by RNA or DNA specific nucleases. Nucleic Acids Res 17: 3373–3386PubMedGoogle Scholar
  89. Stein CA, Subasinghe C, Shinozuka K, Cohen JS (1988) Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res 16: 3209–3221PubMedGoogle Scholar
  90. Stevenson M, Iversen PL (1989) Inhibition of human immunodeficiency virus type 1-mediated cytopathic effects by poly(L-lysine)-conjugated synthetic antisense oligodeoxyribonucleotides. J Gen Virol 70: 673–682Google Scholar
  91. Straubinger RM, Hong K, Friend K, Papahadjopoulos P (1983) Endocytosis of liposomes and intracellular fate of encapsulated molecules: encounter with a low pH compartment after internalization in coated vesicles. Cell 32: 1069–1079PubMedGoogle Scholar
  92. Tomlinson E (1987) Theory and practice of site-specific drug delivery. Adv Drug Delivery Rev 1: 87–198Google Scholar
  93. Uhlenbeck OC (1987) A small catalytic oligoribonucleotide. Nature 328: 596–600PubMedGoogle Scholar
  94. Van Berkel TJC, Kruijt JK, Spanjer MH, Nagelkerke JF, Harkes L, Kempen HJM (1985) The effect of a water-soluble trls-galactoside-terminated cholesterol derivative on the fate of low density lipoproteins and liposomes. J Biol Chem 260: 2694–2699PubMedGoogle Scholar
  95. Van der Krol AR, Lenting PE, Veenstra J, van der Meer IM, Koes RE, Gerats AGM, Mol JNM, Stuitje AR (1988a) An antisense chalcone synthase gene in transgenic plants inhibits flower pigmentation. Nature 333: 866–869Google Scholar
  96. Van der Krol AR, Mol JNM, Stuitje AR (1988b) Modulation of eukaryotic gene expression by complementary RNA or DNA sequences. Biotechniques 6: 958–975PubMedGoogle Scholar
  97. Verspieren P, Cornelissen AWCA, Thuong NT, Helene C, Toulme C (1987) An acridine-linked oligodeoxynucleotide targeted to the common 5′ end of trypanosome mRNAs kills cultured parasites. Gene 61: 307–315PubMedGoogle Scholar
  98. Wagner RW, Nishikura K (1988) Cell cycle expression of RNA duplex unwindase activity by mammalian cells. Mol Cell Biol 8: 770–777PubMedGoogle Scholar
  99. Walder J (1988) Antisense DNA and RNA: progress and prospects. Genes Dev 2: 502–504PubMedGoogle Scholar
  100. Wright S, Huang L (1989) Antibody-directed liposomes as drug-delivery vehicles. Adv Drug Delivery Rev 3: 343–389Google Scholar
  101. Wu JY, Wu CH (1988) Evidence for targeted gene delivery to HEPG2 hepatoma cells in vitro. Biochemistry 27: 887–892PubMedGoogle Scholar
  102. Yakubov LA, Deeva EA, Zarytova VF, Ivanova EM, Ryte AS, Yurchenko LV, Vlassov VV (1989) Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? Proc Natl Acad Sci USA 86: 6454–6458PubMedGoogle Scholar
  103. Yu Z, Chen D, Black RJ, Blake K, Ts’o POP, Miller P, Chang EH (1989) Sequence specific inhibition of in vitro translation of mutated or normal ras p21. J Exp Pathol 4: 97–108PubMedGoogle Scholar
  104. Zamecnik PC, Stephenson M (1978) Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc Natl Acad Sci USA 75: 280–284PubMedGoogle Scholar
  105. Zamecnik PC, Goodchild J, Taguchi Y, Sarin PS (1986) Inhibition of replication and expression of human T-cell lymphotropic virus type II in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA. Proc Natl Acad Sci USA 83: 4143–4146PubMedGoogle Scholar
  106. Zerial A, Thuong NT, Helene C (1987) Selective inhibition of the cytopathic effect of type A influenza viruses by oligodeoxynucleotides covalently linked to an intercalating agent. Nucleic Acids Res 15: 9909–9919PubMedGoogle Scholar
  107. Zon G (1989) Pharmaceutical considerations. In: Cohen JS (ed) Oligodeoxynucleotides: antisense inhibitors of gene expression. Macmillan, London, p 233 Zuckermann RN, Schultz PG (1989) Site-selective of structured RNA by a staphylococcal nuclease-DNA hybrid. Biochemistry 86: 1766–1770Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • G. Degols
  • J.-P. Leonetti
  • B. Lebleu

There are no affiliations available

Personalised recommendations